Paper36849331
Elexacaftor/tezacaftor/ivacaftor projected survival and long-term health outcomes in people with cystic fibrosis homozygous for F508del.
Lopez A and 4 others. J Cyst Fibros, 2023. Cited by 126 papers, by iCite.
Cite this record
ConductScience Library. Elexacaftor/tezacaftor/ivacaftor projected survival and long-term health outcomes in people with cystic fibrosis homozygous for F508del. Papers, record 36849331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36849331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Elexacaftor/tezacaftor/ivacaftor projected survival and long-term health outcomes in people with cystic fibrosis homozygous for F508del.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cystic Fibrosis | Major topic |
| Humans | |
| Child | |
| Adolescent | |
| Cystic Fibrosis Transmembrane Conductance Regulator | |
| Aminophenols | |
| Benzodioxoles | |
| Treatment Outcome | |
| Mutation | |
| Chloride Channel Agonists | |
| Pyrazoles | |
| Pyridines | |
| Pyrrolidines | |
| Quinolones | |
| Indoles |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 37357035 | Median age of survival in the 80s! Is there sufficient evidence to believe it? | https://conductscience.org/library/papers/37357035 |
Source PubMed
Cited by68
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 126 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42790887 | The New Landscape of Cystic Fibrosis in the Era of Highly Effective Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy. | J Mother Child | 2026 | https://conductscience.org/library/papers/42790887 | PubMed |
| 42774065 | Case report end-stage cystic fibrosis with fatal outcome in two siblings from a Chinese family: a 15-year diagnostic odyssey. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42774065 | PubMed |
| 42724683 | Treatment with CFTR modulators and subsequent remission of AA amyloidosis. | Clin Kidney J | 2026 | https://conductscience.org/library/papers/42724683 | PubMed |
| 42509903 | Evolving Cystic Fibrosis Therapy: The Good, the Sad, and the Hopeful. | Children (Basel) | 2026 | https://conductscience.org/library/papers/42509903 | PubMed |
| 42439510 | Effects of elexacaftor/tezacaftor/ivacaftor on the nasal microbial metagenome in cystic fibrosis. | Microbiol Spectr | 2026 | https://conductscience.org/library/papers/42439510 | PubMed |
| 42435399 | Residual disease activity in cystic fibrosis lung disease: implications for clinical management and research. | Am J Respir Crit Care Med | 2026 | https://conductscience.org/library/papers/42435399 | PubMed |
| 42218569 | Remodelling of cystic fibrosis respiratory microbiota in response to extended elexacaftor-tezacaftor-ivacaftor therapy. | Microbiome | 2026 | https://conductscience.org/library/papers/42218569 | PubMed |
| 42107694 | Effectiveness of Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy on Risk of Death for Individuals With Cystic Fibrosis. | Chest | 2026 | https://conductscience.org/library/papers/42107694 | PubMed |
| 41951869 | Cystic fibrosis care today-a narrative review based on views of experts, patients and the public. | Wien Klin Wochenschr | 2026 | https://conductscience.org/library/papers/41951869 | PubMed |
| 41895691 | Updates in Cystic Fibrosis Bone Disease in Adults. | Endocr Pract | 2026 | https://conductscience.org/library/papers/41895691 | PubMed |
| 41878283 | ENHANCE: a community partnership charting the evolution of early-life cystic fibrosis disease manifestations in a new era of management. | ERJ Open Res | 2026 | https://conductscience.org/library/papers/41878283 | PubMed |
| 41878276 | Tracking early cystic fibrosis in the new era. | ERJ Open Res | 2026 | https://conductscience.org/library/papers/41878276 | PubMed |
| 41739723 | Estimation of care costs for individuals with cystic fibrosis at a referral center: cohort study, Salvador, 2005-2022. | Epidemiol Serv Saude | 2026 | https://conductscience.org/library/papers/41739723 | PubMed |
| 41715083 | Prioritising cardiopulmonary exercise testing for adults with cystic fibrosis: a service evaluation. | BMC Pulm Med | 2026 | https://conductscience.org/library/papers/41715083 | PubMed |
| 41588096 | The evolving understanding of cystic fibrosis-related diabetes in the highly effective modulator therapy era: a scoping review. | Diabetologia | 2026 | https://conductscience.org/library/papers/41588096 | PubMed |
| 41587811 | Social determinants of health, cystic fibrosis-related diabetes, and mental health in adult patients with cystic fibrosis: a critical synthesis of narrative review. | Ther Adv Respir Dis | 2026 | https://conductscience.org/library/papers/41587811 | PubMed |
| 41587390 | Exploring Exercise as Airway Clearance in Cystic Fibrosis: A Qualitative Study From the ExACT-CF Feasibility Trial. | Pediatr Pulmonol | 2026 | https://conductscience.org/library/papers/41587390 | PubMed |
| 41238903 | Effectiveness of elexacaftor/tezacaftor/ivacaftor therapy in children and adolescents with cystic fibrosis and normal spirometry. | Pediatr Res | 2026 | https://conductscience.org/library/papers/41238903 | PubMed |
| 41209022 | Cutaneous and Ocular Rosacea Associated with Elexacaftor, Tezacaftor and Ivacaftor, A Treatment for Cystic Fibrosis: A Case Report. | J Pediatr Clin Pract | 2025 | https://conductscience.org/library/papers/41209022 | PubMed |
| 41198444 | Functional CFTR may be required for Prevotella melaninogenica regulation of epithelial cell defense against Staphylococcus aureus. | J Cyst Fibros | 2026 | https://conductscience.org/library/papers/41198444 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CFTR | 1080 | PubTator's text mining | https://conductscience.org/library/genes/1080 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36849331
GET https://conductscience.org/api/papers/v1/36849331/cited_by?page=2